However, we concluded that in a low dose of atorvastatin, ABCB1 and ABCC1 polymorphisms may have an effective impact on atorvastatin efficacy in reduction of LDL-C serum level in Iranian patients with primary hypercholesterolemia. This evidence concerns the gene ABCC1 and familial hypercholesterolemia.